Tag: Demonstrates
Topical phosphodiesterase (PF) 4 inhibitor-07038124 treatment of atopic dermatitis (AD) and plaque psoriasis is both efficacious and well-tolerated among patients, according to recent findings.1 The findings were the result of new research conducted to expand upon existing topical medication options for patients with mild-to-moderate AD or psoriasis, especially given the negative systemic adverse events often […]
Single-strain probiotic treatment had a positive impact on atopic dermatitis (AD) in pediatric patients, according to a study published in Clinical and Translational Allergy.1 The researchers noted that probiotics gained attention for AD treatment after a study found that they helped to reduce eczema in high-risk infants by half.2 “Probiotics may actively fight pathogenic bacteria by […]